Skip to main content
. 2018 Dec 5;6:328. doi: 10.3389/fpubh.2018.00328

Figure 1.

Figure 1

Ongoing model to optimize the managed entry of new drugs across Europe incorporating national and regional stakeholder groups (Reproduced with kind permission of Frontiers in Pharmacology) (3, 59).